Improving treatments for childhood cystic kidney diseases
UAB Childhood Cystic Kidney Disease Core Center (UAB-CCKDCC)
This study is all about finding better ways to understand and treat kidney diseases in kids by looking at how certain proteins affect the disease and testing new treatments using patient samples and models.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project ID | NIH-10884920 on NIH RePORTER |
What this research studies
This research focuses on advancing the understanding and treatment of childhood cystic kidney diseases by collaborating with the PKD Consortium. A multidisciplinary team will work to eliminate barriers in research and develop innovative treatment strategies. The project aims to analyze how defects in specific proteins contribute to kidney disease progression and will provide access to clinical data and biomaterials from affected patients. Additionally, it will create patient-relevant cell and animal models to test potential therapies and improve disease management.
Who could benefit from this research
Good fit: Ideal candidates for this research include children diagnosed with autosomal recessive polycystic kidney disease or related cystic kidney disorders.
Not a fit: Patients with non-cystic kidney diseases or those who do not have a genetic predisposition to cystic kidney disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments and improved outcomes for children suffering from cystic kidney diseases.
How similar studies have performed: Previous research has shown promise in similar approaches to understanding and treating cystic kidney diseases, indicating a potential for success in this area.
Where this research is happening
Birmingham, United States
- University of Alabama at Birmingham — Birmingham, United States (Active)
Researchers
- Principal investigator: Yoder, Bradley K. — University of Alabama at Birmingham
- Study coordinator: Yoder, Bradley K.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.